GSK vs UAMY · P/E 13, $103.31B cap vs rev $14.7M
GlaxoSmithKline PLC ADR (GSK) versus United States Antimony Corporation (UAMY) — a side-by-side from cached financials, not a winner call.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
United States Antimony Corporation (UAMY) is a other industrial metals & mining company listed on NYSE.
GSK does not have a complete income-statement cache yet.
Latest reported UAMY revenue for 2026-06-30 was $14.7M. Net income was -$11.2M. UAMY currently screens at market cap $1.14B.
GSK currently screens at market cap $103.31B and trailing P/E 13.5. UAMY currently screens at market cap $1.14B.
Not investment advice. Open the GSK and UAMY stock pages for the full models.
Not investment advice.